Literature DB >> 15122279

Phage offer a real alternative.

Gary K Schoolnik, William C Summers, James D Watson.   

Abstract

Mesh：

Year:  2004        PMID： 15122279     DOI： 10.1038/nbt0504-505

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West.

Authors:  Dottore Emiliano Fruciano; Shawna Bourne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

2.  Wall teichoic Acid-dependent adsorption of staphylococcal siphovirus and myovirus.

Authors:  Guoqing Xia; Rebecca M Corrigan; Volker Winstel; Christiane Goerke; Angelika Gründling; Andreas Peschel
Journal:  J Bacteriol       Date:  2011-06-03       Impact factor: 3.490

3.  In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.

Authors:  J J Bull; G Otto; I J Molineux
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

4.  Bacteriophage Therapy as a Potential Management Option for Surgical Wound Infections.

Authors:  L Nadareishvili; N Hoyle; N Nakaidze; D Nizharadze; M Kutateladze; N Balarjishvili; E Kutter; N Pruidze
Journal:  Phage (New Rochelle)       Date:  2020-09-16

5.  A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.

Authors:  J J Bull; E R Vimr; I J Molineux
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

6.  Dispersing biofilms with engineered enzymatic bacteriophage.

Authors:  Timothy K Lu; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

7.  The strange history of phage therapy.

Authors:  William C Summers
Journal:  Bacteriophage       Date:  2012-04-01

8.  Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

Authors:  Vivek Daniel Paul; Sudarson Sundarrajan; Sanjeev Saravanan Rajagopalan; Sukumar Hariharan; Nanjundappa Kempashanaiah; Sriram Padmanabhan; Bharathi Sriram; Janakiraman Ramachandran
Journal:  BMC Microbiol       Date:  2011-08-31       Impact factor: 3.605

9.  Enhancing and initiating phage-based therapies.

Authors:  Philip Serwer; Elena T Wright; Juan T Chang; Xiangan Liu
Journal:  Bacteriophage       Date:  2014-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.